2 Results: matthias+klugmann

Sort By:

Developing Better Treatments for Hearing Loss and Tourette’s, Parkinson’s and Alzheimer’s Diseases

A simple ‘coating’ to a cochlear device - could hold the key to better treatments for hearing loss and central nervous system diseases The Discovery A modified cochlear device - for 'close-field' electroporation Central Nervous System (CNS) diseases affect millions of people. CNS diseases can affect the brain or the spinal cord resulting...

Published: 3/13/2014

Category(s): Biotechnology, Therapeutics

Keywords(s): Biomedical Engineering, Biotech, CNS Diseases, Drug Development, Medical/Clinical, Pharmaceutical

Inventor(s): Gary Housley, Jeremy Pinyon, Matthias Klugmann

Genistein - a neuroprotective treatment for brain injury arising from excessive glutamate release such as occurs with stroke and epilepsy.

Background Traumatic brain injury is a major medical problem globally and is one of the leading causes of death and disability. There is no known treatment for stroke or ischaemic brain injury. A stroke is a medical emergency and can cause permanent brain damage and death. Risk factors for stroke include old age, high blood pressure, previous stroke...

Published: 3/6/2014

Category(s): Biotechnology, Therapeutics

Keywords(s): Biotech, Chemical, Drug Development, Life Sciences, Medical/Clinical, Natural therapies, Pharmaceutical, Veterinarian

Inventor(s): Gary Housley, Youngsoo Kim, Paul Bertrand, Andrew Moorhouse, Ann Chi Yan Wong, Amanda Craig, John Power, Matthias Klugmann, Arun Krishnan, Renee Morris